Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
510 people get OPTR articles and Market Currents by email alert.
Get email alerts on OPTR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (Mon, 4:04PM)
-
PR Newswire (May 9, 2013)
-
-
PR Newswire (Apr 26, 2013)
-
PR Newswire (Mar 15, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 27, 2013)
-
-
PR Newswire (Feb 7, 2013)
-
PR Newswire (Feb 1, 2013)
-
-
PR Newswire (Jan 7, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Optimer Pharmaceuticals' Encouraging FDA NewsZacks Investment Research • Tue, Jul 5, 2011 -
-
-
-
-
-
Promising Year Ahead for Optimer PharmaZacks Investment Research • Mon, Jun 29, 2009
-
-
-
-
-
-
-
-
-
-
-
-
-
Fund Holdings For 3 Healthcare Stocks, And 4 Other SellsGuruFundPicks • Mon, Jun 18, 2012
-
-
-
-
-
9 Rallying Biotech Stocks Being Snapped Up By Hedge FundsKapitall • Tue, May 15, 2012
-
-
5 Hedge Fund Biotech Stock Picks With Significant Short CoveringKapitall • Tue, Apr 24, 2012
-
-
Optimer Pharmaceuticals, Inc. Q4 2008 Earnings Call TranscriptWed, Mar 11, 2009
-
Optimer Pharmaceuticals, Inc. Q4 2007 Earnings Call TranscriptSun, Apr 27, 2008
-
PR Newswire (Mon, 4:04PM)
-
PR Newswire (May 9, 2013)
-
PR Newswire (Apr 26, 2013)
-
PR Newswire (Mar 15, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 7, 2013)
-
PR Newswire (Feb 1, 2013)
-
PR Newswire (Jan 7, 2013)
-
PR Newswire (Dec 24, 2012)
-
PR Newswire (Dec 20, 2012)
-
PR Newswire (Dec 5, 2012)
-
PR Newswire (Nov 7, 2012)
-
PR Newswire (Nov 1, 2012)
OPTR vs. ETF Alternatives
Company Description
Currently, there's no company description for OPTR.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 15, 4:01 PM Shares of Optimer Pharmaceutical (OPTR +15%) spike into the close on rumors that Cubist Pharmaceutical (CBST -0.5%) lobbed a $1B bid for OPTR prior to the sales process. Comment! [Healthcare, M&A, On the Move]
- Monday, May 13, 5:09 PM Shares of Optimer Pharmaceutical (OPTR +14%) ramped up into the close on reports that AstraZeneca (AZN), Astellas Pharma (ALPMY.PK) and Cubist Pharmaceuticals (CBST) are among the first round bidders for the antibiotic manufacturer. OPTR disclosed almost three months ago that they were working with Centerview Partners and JPMorgan to explore its strategic options, including a potential sale. Comment! [Healthcare, On the Move, M&A]
-
Ryan Mallory
Fuinhaz Setups for February 27 2013 | $BBRY $CCUR $DLTR $OPTR $ZAGG http://bit.ly/YXtYkH - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
LifeSci Advisors
OPTR - I just posted a survey of physicians on their expected use of DIFICID on my website: http://bit.ly/nEORWJ/ - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES